Stay updated on REOLYSIN in KRAS Mutant CRC Clinical Trial
Sign up to get notified when there's something new on the REOLYSIN in KRAS Mutant CRC Clinical Trial page.

Latest updates to the REOLYSIN in KRAS Mutant CRC Clinical Trial page
- Check2 days agoChange DetectedThe page’s footer revision label was updated from v3.5.3 to v3.5.4, indicating a minor version update.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe page revision tag changed from v3.5.2 to v3.5.3, indicating a small page version update rather than substantive changes to the study details.SummaryDifference0.1%

- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedFooter revision indicators were updated: added Revision: v3.5.2 and removed Revision: v3.5.0.SummaryDifference0.1%

- Check52 days agoChange DetectedRevision updated to v3.5.0, replacing the previous v3.4.3.SummaryDifference0.1%

- Check67 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check81 days agoChange DetectedNo additions or deletions were observed. The page content appears unchanged.SummaryDifference0.1%

Stay in the know with updates to REOLYSIN in KRAS Mutant CRC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the REOLYSIN in KRAS Mutant CRC Clinical Trial page.